New research reveals that people who stop using popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle plans.
Published data in a prominent medical journal demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"Individuals purchasing such drugs need to be informed of the danger of fast weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
This pace of recovery means a reversion to original weight in about a year and a half.
Analyzing Therapies
The study, which reviewed dozens of studies involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise typically have a less rapid creep back—around 100 grams monthly—after stopping.
Understanding the Rapid Regain
Nutrition scientists propose the mechanism of the drugs accounts for the heightened rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to hunger is unsuppressed, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines recommend the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians say that, given the likelihood of weight regain, the therapy is often ongoing.
This perspective is supported by drug manufacturers, who say that the results "underscore the long-term nature of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Individuals who have discontinued the jabs explain a intense resurgence of cravings.
"It was like a trigger flipping and you become extremely hungry," described a patient.
The struggle is worsened if patients have not established lasting dietary or behavioural changes during treatment.
Widespread Use
Survey data suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Use is greater among females than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are powerful agents for weight loss, they are not a standalone cure and lasting health benefits hinges on integrated lifestyle management.
